# A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19

> **NCT04362059** · NA · COMPLETED · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 20 (actual)

## Conditions studied

- Respiratory Infections

## Interventions

- **DEVICE:** COVSurf Drug Delivery System
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT04362059
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-18
- **Primary completion:** 2022-11-30
- **Final completion:** 2023-01-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-09-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04362059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04362059, "A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04362059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*